ADIPOQ and metabolic dysfunction-associated steatohepatitis: The beneficial effects of adiponectin leading to the amelioration of NASH and liver fibrosis occurs by inhibition of Kupffer cells and HSC activation that are responsible for the secretion of anti-inflammatory cytokines [62].